{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T02:23:41Z","timestamp":1783477421346,"version":"3.55.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Patients with AKI experience higher rates of heart failure (HF). This study seeks to identify criteria to assess the risk of heart failure post-hospitalization, with a special focus on AKI patients. We hypothesized that the combined use of 9 vascular biomarkers would predict future heart failure events after AKI. Using a study of 1497 hospitalized patients with and without AKI, we found that these 9 vascular biomarkers successfully stratified patients into different risk groups for HF, and were able to improve prediction of HF when added to routine clinical variables.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Using the ASSESS-AKI cohort, we performed an unsupervised spectral cluster analysis with 9 plasma biomarkers measured at 3 months post-hospitalization <jats:italic>[Angiopoietin (angpt)-1<\/jats:italic>,<jats:italic> angpt-2<\/jats:italic>,<jats:italic> vascular endothelial growth factor (VEGF)-A<\/jats:italic>,<jats:italic> VEGF-C<\/jats:italic>,<jats:italic> VEGF-d<\/jats:italic>,<jats:italic> VEGF receptor 1 (R1)<\/jats:italic>,<jats:italic> solubleTie-2 (sTie-2)<\/jats:italic>,<jats:italic> placental growth factor (PlGF)<\/jats:italic>,<jats:italic> and basic fibroblast growth factor (bFGF)]<\/jats:italic> in 1,497 patients, half of whom had AKI. We used a Cox regression analysis to evaluate the associations between the clusters and HF. Models were adjusted for demographics, cardiovascular disease risk factors, medications, ICU status, lung disease, sepsis, clinical center, and 3-month post-discharge serum creatinine and proteinuria. We calculated change in the area under the curve (AUC) for the prediction of HF or death at 3 years by adding the biomarkers to a clinical model selected by a penalized regression with LASSO. We also calculated a net reclassification index for the addition of the biomarkers to the clinical model.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Three biomarker-derived clusters were identified: Cluster 1 [<jats:italic>n<\/jats:italic>\u2009=\u2009302, Vascular Injury (Injury) Phenotype] had higher levels of injury markers, whereas Cluster 2 [<jats:italic>n<\/jats:italic>\u2009=\u2009728, Vascular Repair (Repair) Phenotype] had higher levels of repair markers. Cluster 3 (<jats:italic>n<\/jats:italic>\u2009=\u2009467) had lower levels of all markers (Dormant Phenotype). Across the entire cohort, those with the Injury Phenotype had twofold higher risk of a HF event compared to the Repair Phenotype [aHR 2.24 (95% CI: 1.57\u20133.19)] and noted in both participants with AKI [aHR 2.12 (95% CI: 1.35\u20133.34)] and without AKI [aHR 2.94 (95%CI: 1.57\u20135.50)]. The Dormant Phenotype was associated with higher risk of HF events only in participants without AKI. The AUC for the prediction of HF event or death at 3 years by the biomarkers was 0.76 (95% CI: 0.73\u20130.80), 0.77 (95% CI: 0.73\u20130.80) for the clinical model, and 0.80 (95% CI: 0.77\u20130.83) for the combined model. The addition of the biomarkers significantly improved reclassification of HF event or death.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Vascular biomarkers can be used to derive phenotypes capable of stratifying future risk of HF events in recently hospitalized patients with or without AKI.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12882-025-04169-1","type":"journal-article","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T13:32:07Z","timestamp":1748871127000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Using vascular biomarkers to assess heart failure event risk in hospitalized patients with and without AKI"],"prefix":"10.1186","volume":"26","author":[{"given":"Audrey A.","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Simone","family":"Andrawis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis P.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wassim","family":"Obeid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather Thiessen","family":"Philbrook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan S.","family":"Go","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. Alp","family":"Ikizler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward D.","family":"Siew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vernon M.","family":"Chinchilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Yuan","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit X.","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Brian","family":"Reeves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David K.","family":"Prince","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavan","family":"Bhatraju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve G.","family":"Coca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen D.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul L.","family":"Kimmel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James S.","family":"Kaufman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark W.","family":"Wurfel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Himmelfarb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chirag R.","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherry G.","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the ASSESS-AKI Consortium*","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,2]]},"reference":[{"key":"4169_CR1","doi-asserted-by":"publisher","first-page":"2810","DOI":"10.1161\/01.CIR.0000021745.45349.BB","volume":"105","author":"DK Moser","year":"2002","unstructured":"Moser DK, Mann DL. Improving outcomes in heart failure: it\u2019s not unusual beyond usual care. Circulation. 2002;105:2810\u20132.","journal-title":"Circulation"},{"key":"4169_CR2","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1002\/ehf2.12595","volume":"7","author":"JL Holgado","year":"2020","unstructured":"Holgado JL, Lopez C, Fernandez A, et al. Acute kidney injury in heart failure: a population study. ESC Heart Fail. 2020;7:415\u201322.","journal-title":"ESC Heart Fail"},{"key":"4169_CR3","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1681\/ASN.2016010105","volume":"28","author":"A Odutayo","year":"2017","unstructured":"Odutayo A, Wong CX, Farkouh M, et al. AKI and Long-Term risk for cardiovascular events and mortality. J Am Soc Nephrology: JASN. 2017;28:377\u201387.","journal-title":"J Am Soc Nephrology: JASN"},{"key":"4169_CR4","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1007\/s00134-015-3934-7","volume":"41","author":"EAJ Hoste","year":"2015","unstructured":"Hoste EAJ, Bagshaw SM, Bellomo R, et al. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med. 2015;41:1411\u201323.","journal-title":"Intensive Care Med"},{"key":"4169_CR5","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1681\/ASN.2021060757","volume":"33","author":"SG Mansour","year":"2022","unstructured":"Mansour SG, Bhatraju PK, Coca SG, et al. Angiopoietins as prognostic markers for future kidney disease and heart failure events after acute kidney injury. J Am Soc Nephrology: JASN. 2022;33:613\u201327.","journal-title":"J Am Soc Nephrology: JASN"},{"key":"4169_CR6","doi-asserted-by":"publisher","first-page":"267257","DOI":"10.4061\/2011\/267257","volume":"2011","author":"CR Martens","year":"2011","unstructured":"Martens CR, Edwards DG. Peripheral vascular dysfunction in chronic kidney disease. Cardiol Res Pract. 2011;2011:267257.","journal-title":"Cardiol Res Pract"},{"key":"4169_CR7","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.3389\/fimmu.2018.01130","volume":"9","author":"H Cardinal","year":"2018","unstructured":"Cardinal H, Dieude M, Hebert MJ. Endothelial dysfunction in kidney transplantation. Front Immunol. 2018;9:1130.","journal-title":"Front Immunol"},{"key":"4169_CR8","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1681\/ASN.2005121250","volume":"17","author":"ME Reinders","year":"2006","unstructured":"Reinders ME, Rabelink TJ, Briscoe DM. Angiogenesis and endothelial cell repair in renal disease and allograft rejection. J Am Soc Nephrology: JASN. 2006;17:932\u201342.","journal-title":"J Am Soc Nephrology: JASN"},{"key":"4169_CR9","doi-asserted-by":"crossref","unstructured":"Tietjen GT, Hosgood SA, DiRito J et al. Nanoparticle targeting to the endothelium during normothermic machine perfusion of human kidneys. Sci Transl Med 2017;9.","DOI":"10.1126\/scitranslmed.aam6764"},{"key":"4169_CR10","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1159\/000447607","volume":"134","author":"HM Perry","year":"2016","unstructured":"Perry HM, Okusa MD. Endothelial dysfunction in renal interstitial fibrosis. Nephron. 2016;134:167\u201371.","journal-title":"Nephron"},{"key":"4169_CR11","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1002\/path.3964","volume":"226","author":"AH Salmon","year":"2012","unstructured":"Salmon AH, Satchell SC. Endothelial glycocalyx dysfunction in disease: albuminuria and increased microvascular permeability. J Pathol. 2012;226:562\u201374.","journal-title":"J Pathol"},{"key":"4169_CR12","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.1038\/s41467-022-30682-0","volume":"13","author":"F Peisker","year":"2022","unstructured":"Peisker F, Halder M, Nagai J, et al. Mapping the cardiac vascular niche in heart failure. Nat Commun. 2022;13:3027.","journal-title":"Nat Commun"},{"key":"4169_CR13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s10741-019-09881-3","volume":"25","author":"C Zuchi","year":"2020","unstructured":"Zuchi C, Tritto I, Carluccio E, Mattei C, Cattadori G, Ambrosio G. Role of endothelial dysfunction in heart failure. Heart Fail Rev. 2020;25:21\u201330.","journal-title":"Heart Fail Rev"},{"key":"4169_CR14","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1161\/ATVBAHA.116.306940","volume":"36","author":"CM Boulanger","year":"2016","unstructured":"Boulanger CM, Endothelium. Arterioscler Thromb Vasc Biol. 2016;36:e26\u201331.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"4169_CR15","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.ejheart.2007.12.007","volume":"10","author":"PC Colombo","year":"2008","unstructured":"Colombo PC, Onat D, Sabbah HN. Acute heart failure as acute endothelitis--Interaction of fluid overload and endothelial dysfunction. Eur J Heart Fail. 2008;10:170\u20135.","journal-title":"Eur J Heart Fail"},{"key":"4169_CR16","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.3389\/fphar.2018.01308","volume":"9","author":"BK Ooi","year":"2018","unstructured":"Ooi BK, Chan KG, Goh BH, Yap WH. The role of natural products in targeting cardiovascular diseases via Nrf2 pathway: novel molecular mechanisms and therapeutic approaches. Front Pharmacol. 2018;9:1308.","journal-title":"Front Pharmacol"},{"key":"4169_CR17","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1161\/ATVBAHA.121.317319","volume":"42","author":"A Abelanet","year":"2022","unstructured":"Abelanet A, Camoin M, Rubin S, et al. Increased capillary permeability in heart induces diastolic dysfunction independently of inflammation, fibrosis, or cardiomyocyte dysfunction. Arterioscler Thromb Vasc Biol. 2022;42:745\u201363.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"4169_CR18","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1681\/ASN.2017030258","volume":"29","author":"P Iatropoulos","year":"2018","unstructured":"Iatropoulos P, Daina E, Curreri M, et al. Cluster analysis identifies distinct pathogenetic patterns in C3 glomerulopathies\/immune Complex-Mediated membranoproliferative GN. J Am Soc Nephrology: JASN. 2018;29:283\u201394.","journal-title":"J Am Soc Nephrology: JASN"},{"key":"4169_CR19","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1471-2369-11-22","volume":"11","author":"AS Go","year":"2010","unstructured":"Go AS, Parikh CR, Ikizler TA, et al. The assessment, serial evaluation, and subsequent sequelae of acute kidney injury (ASSESS-AKI) study: design and methods. BMC Nephrol. 2010;11:22.","journal-title":"BMC Nephrol"},{"key":"4169_CR20","unstructured":"Ikizler TA, Parikh CR, Himmelfarb J et al. A prospective cohort study of acute kidney injury and kidney outcomes, cardiovascular events, and death. Kidney Int. 2020."},{"key":"4169_CR21","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1056\/NEJM197112232852601","volume":"285","author":"PA McKee","year":"1971","unstructured":"McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham study. N Engl J Med. 1971;285:1441\u20136.","journal-title":"N Engl J Med"},{"key":"4169_CR22","unstructured":"Ng A, Jordan M, Weiss Y. On spectral clustering: analysis and an algorithm. NIPS\u201901: Proceedings of the 14th International Conference on Neural Information Processing Systems: Natural and Synthetic. 2001:849\u2013856."},{"key":"4169_CR23","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.1172\/JCI40205","volume":"120","author":"IZ Jaffe","year":"2010","unstructured":"Jaffe IZ, Newfell BG, Aronovitz M, et al. Placental growth factor mediates aldosterone-dependent vascular injury in mice. J Clin Investig. 2010;120:3891\u2013900.","journal-title":"J Clin Investig"},{"key":"4169_CR24","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.bbrc.2005.04.108","volume":"332","author":"N Singh","year":"2005","unstructured":"Singh N, Macnamara E, Rashid S, et al. Systemic soluble Tie2 expression inhibits and regresses corneal neovascularization. Biochem Biophys Res Commun. 2005;332:194\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"4169_CR25","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/path.4708","volume":"239","author":"T Sato","year":"2016","unstructured":"Sato T, Paquet-Fifield S, Harris NC, et al. VEGF-D promotes pulmonary oedema in hyperoxic acute lung injury. J Pathol. 2016;239:152\u201361.","journal-title":"J Pathol"},{"key":"4169_CR26","doi-asserted-by":"publisher","first-page":"19979","DOI":"10.1038\/s41598-021-99470-y","volume":"11","author":"M Greco","year":"2021","unstructured":"Greco M, Suppressa S, Lazzari RA, Sicuro F, Catanese C, Lobreglio G. sFlt-1 and CA 15.3 are indicators of endothelial damage and pulmonary fibrosis in SARS-CoV-2 infection. Sci Rep. 2021;11:19979.","journal-title":"Sci Rep"},{"key":"4169_CR27","doi-asserted-by":"publisher","first-page":"5018","DOI":"10.1172\/JCI99659","volume":"128","author":"SJ Lee","year":"2018","unstructured":"Lee SJ, Lee CK, Kang S, et al. Angiopoietin-2 exacerbates cardiac hypoxia and inflammation after myocardial infarction. J Clin Investig. 2018;128:5018\u201333.","journal-title":"J Clin Investig"},{"key":"4169_CR28","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1172\/JCI46322","volume":"121","author":"M Jeansson","year":"2011","unstructured":"Jeansson M, Gawlik A, Anderson G, et al. Angiopoietin-1 is essential in mouse vasculature during development and in response to injury. J Clin Investig. 2011;121:2278\u201389.","journal-title":"J Clin Investig"},{"key":"4169_CR29","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1080\/08977194.2022.2118119","volume":"40","author":"L Guo","year":"2022","unstructured":"Guo L, Wei B, Pan F, Wulan H, Cai M. Effects of dual-gene modification on biological characteristics of vascular endothelial cells and their significance as reserving cells for chronic wound repair. Growth Factors. 2022;40:221\u201330.","journal-title":"Growth Factors"},{"key":"4169_CR30","doi-asserted-by":"crossref","unstructured":"Glinton KE, Ma W, Lantz C et al. Macrophage-produced VEGFC is induced by efferocytosis to ameliorate cardiac injury and inflammation. J Clin Investig 2022;132.","DOI":"10.1172\/JCI140685"},{"key":"4169_CR31","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/s13287-017-0684-1","volume":"8","author":"L Li","year":"2017","unstructured":"Li L, Liu H, Xu C, et al. VEGF promotes endothelial progenitor cell differentiation and vascular repair through connexin 43. Stem Cell Res Ther. 2017;8:237.","journal-title":"Stem Cell Res Ther"},{"key":"4169_CR32","first-page":"581","volume":"26","author":"JL Koyner","year":"2020","unstructured":"Koyner JL, Haines RW, Bouchard J. Individualized acute kidney injury after care. Curr Opin Crit Care. 2020;26:581\u20139.","journal-title":"Curr Opin Crit Care"},{"key":"4169_CR33","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1136\/heartjnl-2016-310794","volume":"103","author":"C Tuegel","year":"2017","unstructured":"Tuegel C, Bansal N. Heart failure in patients with kidney disease. Heart. 2017;103:1848\u201353.","journal-title":"Heart"},{"key":"4169_CR34","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.kint.2022.06.013","volume":"102","author":"P Rossing","year":"2022","unstructured":"Rossing P, Caramori ML, Chan JCN, et al. Executive summary of the KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease: an update based on rapidly emerging new evidence. Kidney Int. 2022;102:990\u20139.","journal-title":"Kidney Int"},{"key":"4169_CR35","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s12859-022-04680-4","volume":"23","author":"W Shao","year":"2022","unstructured":"Shao W, Luo X, Zhang Z, et al. Application of unsupervised deep learning algorithms for identification of specific clusters of chronic cough patients from EMR data. BMC Bioinformatics. 2022;23:140.","journal-title":"BMC Bioinformatics"},{"key":"4169_CR36","doi-asserted-by":"publisher","first-page":"n2281","DOI":"10.1136\/bmj.n2281","volume":"375","author":"CL Andaur Navarro","year":"2021","unstructured":"Andaur Navarro CL, Damen JAA, Takada T, et al. Risk of bias in studies on prediction models developed using supervised machine learning techniques: systematic review. BMJ. 2021;375:n2281.","journal-title":"BMJ"},{"issue":"3","key":"4169_CR37","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1681\/ASN.2021060757","volume":"33","author":"SG Mansour","year":"2022","unstructured":"Mansour SG, Bhatraju PK, Coca SG, et al. Angiopoietins as prognostic markers for future kidney disease and heart failure events after acute kidney injury. J Am Soc Nephrol. 2022;33(3):613\u201327.","journal-title":"J Am Soc Nephrol"},{"key":"4169_CR38","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/pds.4394","volume":"27","author":"X Zhang","year":"2018","unstructured":"Zhang X, Faries DE, Li H, Stamey JD, Imbens GW. Addressing unmeasured confounding in comparative observational research. Pharmacoepidemiol Drug Saf. 2018;27:373\u201382.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"4169_CR39","doi-asserted-by":"crossref","unstructured":"Nguyen TTU, Kim H, Chae YJ, Jung JH, Kim W. Serum VEGF-D level is correlated with renal dysfunction and proteinuria in patients with diabetic chronic kidney disease. Med (Baltim). 2022;101(7).","DOI":"10.1097\/MD.0000000000028804"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04169-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04169-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04169-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T17:01:05Z","timestamp":1757178065000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-025-04169-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,2]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4169"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04169-1","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,2]]},"assertion":[{"value":"1 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article has been updated to amend the license information.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Institutional Review Boards of the Data Coordinating Center and participating Clinical Research Centers\u2019 institutions approved the study. The study was conducted in accordance with the Declaration of Helsinki, and informed consent to participate was obtained from all of the participants in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"271"}}